Please select the option that best describes you:
How are you incorporating abscopal radiation into your practice for metastatic NSCLC?
What is the best evidence for what dose to use? When would you give it in relation to the checkpoint inhibitors? Which metastatic sites do you choose to radiate?
Answer from: Radiation Oncologist at Academic Institution
There is not enough evidence to guide our daily clinical practice about radiation abscopal effect off protocol. However, in stage IV NSCLC, we can use RT to:
1. Eliminate/control chemo or target therapy resistant or persistent primary and oligo-metastases
2. Concurrent SABR with targeted the...
Sign in or Register to read more